Unity Biotechnology, Inc. (UBX)

Unity Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	19.8	12.74	33.46	17.81	38.92
Short-Term Investments	23.4	82.06	55.17	79.89	90.02
Cash & Cash Equivalents	43.2	94.8	88.63	97.7	128.93
Cash Growth	-54.43%	6.96%	-9.29%	-24.23%	-24.90%
Other Current Assets	3.4	1.74	1.88	3.17	0.55
Total Current Assets	46.61	96.54	90.5	100.87	129.49
Property, Plant & Equipment	18.06	26.87	31.23	36.14	16.64
Long-Term Investments	0.9	0.9	2.89	19.32	3.03
Other Long-Term Assets	0.13	0.05	0.09	0	2.07
Total Long-Term Assets	19.09	27.82	34.21	55.45	21.73
Total Assets	65.69	124.35	124.71	156.32	151.22
Accounts Payable	1.38	1.79	1.99	2.56	5.19
Deferred Revenue	0	0	0.22	0	0
Current Debt	0	9.48	4.02	0	0
Other Current Liabilities	6.46	8.35	10.4	11.91	12.03
Total Current Liabilities	7.84	19.62	16.62	14.46	17.22
Long-Term Debt	23.54	37.88	48.5	58.98	0
Other Long-Term Liabilities	5.91	10.76	0.02	0	13.3
Total Long-Term Liabilities	29.45	48.65	48.53	58.98	13.3
Total Liabilities	37.29	68.27	65.14	73.44	30.51
Total Debt	23.54	47.36	52.52	58.98	0
Debt Growth	-50.30%	-9.83%	-10.95%	-	-
Retained Earnings	-484.35	-444.49	-400.02	-339.3	-245.46
Comprehensive Income	-0.02	-0.25	-0.04	0.01	0.09
Shareholders' Equity	28.4	56.08	59.57	82.88	120.71
Net Cash / Debt	19.66	47.44	36.1	38.72	128.93
Net Cash / Debt Growth	-58.55%	31.39%	-6.76%	-69.97%	-24.90%
Net Cash Per Share	1.33	5.00	6.47	7.61	29.56
Working Capital	38.77	76.92	73.89	86.4	112.27
Book Value Per Share	1.92	5.91	10.67	16.29	27.67

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).